| Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension. | |
| | |
MedLine Citation:
|
PMID: 22435711 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIM: Due to their effect on altering physiological interactions between vasodilator and vasoconstrictor autacoids in normal pregnancies, antidepressants may be associated with the risk of pregnancy-induced hypertension. We evaluated the impact of antidepressant use during pregnancy on the risk of pregnancy-induced hypertension. METHODS: We conducted a nested case-control study within the Quebec Pregnancy Registry, built by linkage of provincial medical, pharmaceutical, hospital and birth databases. We identified 1216 women with a diagnosis of pregnancy-induced hypertension with or without pre-eclampsia and with no history of hypertension before pregnancy. We randomly selected 10 controls for each case, matched on case index date (date of diagnosis) and gestational age. Odds ratios (OR) were calculated using conditional logistic regression models, adjusting for sociodemographic characteristics, maternal depression, anxiety, other chronic conditions, medication use and health service utilization. RESULTS: Among cases, 45 (3.7%) had used antidepressants during pregnancy compared with 300 (2.5%) in the control group (OR 1.52, 95% CI 1.10, 2.09). After adjusting for potential confounders, use of antidepressants during pregnancy was significantly associated with increased risk of pregnancy-induced hypertension (OR 1.53, 95% CI 1.01, 2.33). In stratified analyses, use of selective serotonin re-uptake inhibitors (OR 1.60, 95% CI 1.00, 2.55), and more specifically, paroxetine (OR 1.81, 95% CI 1.02, 3.23) was associated with risk of pregnancy-induced hypertension. CONCLUSIONS: Women who use antidepressants during pregnancy are at increased risk of pregnancy-induced hypertension with or without pre-eclampsia above and beyond the risk that could be attributed to their depression or anxiety disorders. |
| | |
Authors:
|
Mary A De Vera; Anick Bérard |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: British journal of clinical pharmacology Volume: 74 ISSN: 1365-2125 ISO Abbreviation: Br J Clin Pharmacol Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-07-11 Completed Date: 2012-11-13 Revised Date: 2013-05-16 |
Medline Journal Info:
|
Nlm Unique ID: 7503323 Medline TA: Br J Clin Pharmacol Country: England |
Other Details:
|
Languages: eng Pagination: 362-9 Citation Subset: IM |
Copyright Information:
|
© 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society. |
Affiliation:
|
Faculty of Pharmacy, University of Montreal CHU Sainte Justine Research Center, Montréal, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antidepressive Agents / adverse effects* Case-Control Studies Female Humans Hypertension, Pregnancy-Induced / chemically induced* Logistic Models Multivariate Analysis Odds Ratio Paroxetine / adverse effects Pregnancy Pregnancy Complications / drug therapy* Prospective Studies Quebec Registries Risk Assessment Risk Factors Serotonin Uptake Inhibitors / adverse effects Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Antidepressive Agents; 0/Serotonin Uptake Inhibitors; 61869-08-7/Paroxetine |
| Comments/Corrections | |
Comment In:
|
Br J Clin Pharmacol. 2013 May;75(5):1373-4
[PMID:
22994305
]
Br J Clin Pharmacol. 2013 May;75(5):1375-6 [PMID: 23116518 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Estrone is Neuroprotective in Rats Following Traumatic Brain Injury.
Next Document: The promoter architectural landscape of the Salmonella PhoP regulon.